Cantor sees six changes to Nasdaq 100 Index in December rebalance

Cantor Fitzgerald’s “Tracker Quants” laid out its forecasted changes for the upcoming Nasdaq 100 Index review. Nasdaq will implement its annual rebalance for its100 Index as of the close of December 20 and confirm the changes on December 13, Cantor tells investors in a research note. The firm sees Palantir (PLTR), MicroStrategy (MSTR) and Axon (AXON) being added to the Nasdaq 100 with Supermicro (SMCI), Moderna (MRNA) and Illumina (ILMN) being removed.